Search

Your search keyword '"Majano, P. L."' showing total 166 results

Search Constraints

Start Over You searched for: "Majano, P. L." Remove constraint "Majano, P. L."
166 results on '"Majano, P. L."'

Search Results

7. Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture.

11. Apicobasal Polarity Controls Lymphocyte Adhesion to Hepatic Epithelial Cells

12. Intrahepatic enhanced expression of beta2-microglobulin conformational epitope in acute liver allograft rejection: evidence of modulation by glucocorticoids.

13. Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix

17. The trajectory of vesicular proteomic signatures from HBV‐HCC by chitosan‐magnetic bead‐based separation and DIA‐proteomic analysis.

21. FGF21 upregulation by hepatitis C virus via the eIF2α-ATF4 pathway: implications for interferon signaling suppression and TRIM31-mediated TSC degradation.

22. Pistacia vera L. as natural source against antimicrobial and antiviral resistance.

23. Effect of ozone gas on viral kinetics and liver histopathology in hepatitis C patients.

24. Inverted apicobasal polarity in health and disease.

26. CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells.

27. Medicinal plant molecules against hepatitis C virus: Current status and future prospect.

29. Carbosilane dendritic nanostructures, highly versatile platforms for pharmaceutical applications.

30. Danshensu attenuated lipopolysaccharide‐induced LX‐2 and T6 cells activation through regulation of ferroptosis.

31. Differentially Expressed microRNAs in Peritoneal Dialysis Effluent-Derived Exosomes from the Patients with Ultrafiltration Failure.

32. Calcium Ions Signaling: Targets for Attack and Utilization by Viruses.

33. Integrative Metabolome and Transcriptome Analysis of Flavonoid Biosynthesis Genes in Broussonetia papyrifera Leaves From the Perspective of Sex Differentiation.

34. Baseline and time‐updated factors in preclinical development of anionic dendrimers as successful anti‐HIV‐1 vaginal microbicides.

35. Activation of the Ca 2+ /NFAT Pathway by Assembly of Hepatitis C Virus Core Protein into Nucleocapsid-like Particles.

37. Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy.

38. Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.

39. Quercetin and its derivates as antiviral potentials: A comprehensive review.

40. Co-infections as Modulators of Disease Outcome: Minor Players or Major Players?

41. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles.

42. Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway.

43. Dinitrosyl Iron Complexes with Thiol-Containing Ligands Can Suppress Viral Infections as Donors of the Nitrosonium Cation (Hypothesis).

44. The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook.

45. The Role of Chemokines in the Pathogenesis of HTLV-1.

46. Carbosilane dendritic nanostructures, highly versatile platforms for pharmaceutical applications.

47. Three‐dimensional cryogel matrix for spheroid formation and anti‐cancer drug screening.

48. Complexity on modulation of NF‐κB pathways by hepatitis B and C: A double‐edged sword in hepatocarcinogenesis.

Catalog

Books, media, physical & digital resources